RET GPCR Activation Assay for G-Protein Subtype Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for determining the modulation of G protein-coupled receptor (GPCR) activation are cumbersome, require radioactive materials, and cannot easily discriminate between different subtypes of alpha G-proteins without modifying the GPCRs and G-proteins expressed by cells.

Innovation Solution

A method using fluorescence-based Resonance Energy Transfer (RET) to detect nonhydrolyzable or slowly hydrolyzable GTP labeled with RET partners, allowing discrimination between full and empty forms of alpha G-proteins, without the need for washing steps or membrane preparation specific to each subtype, enabling high-throughput screening.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If energy transfer techniques (FRET/BRET) are used to detect GPCR activation, then measurement sensitivity is improved, but device complexity increases due to requirements for fusion proteins and multiple membrane preparations

Engineering Contradiction:
Improvedetection sensitivityVSAvoidassay complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention extracts and labels only the specific components needed for detection (GTP analogues and alpha G-protein subunits) rather than requiring fusion of entire proteins. This selective labeling simplifies the assay by removing the complexity of fusion protein construction while maintaining detection sensitivity through RET between the labeled components.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention creates a universal assay platform that can detect multiple alpha G-protein subtypes (Gαs, Gαi, Gαq/11) using the same basic RET methodology. By using subtype-specific antibodies against the labeled alpha subunits, a single membrane preparation can be used to study multiple receptor-G protein interactions, eliminating the need for separate preparations for each subtype.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If multiple membrane preparations are prepared for each alpha G-protein subtype, then discrimination between subtypes is improved, but productivity decreases due to time-consuming preparation steps

Engineering Contradiction:
Improvesubtype discriminationVSAvoidscreening throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The invention enables a single membrane preparation to serve multiple detection purposes by labeling alpha G-protein subunits with RET partners. Subtype-specific antibodies can then distinguish between different alpha subunit types (Gαs, Gαi, Gαq/11) within the same preparation, achieving both subtype discrimination and high throughput without requiring separate preparations for each subtype.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If radiolabeled ligands are used for affinity assays, then measurement reliability is improved, but safety hazards increase due to radioactive material requirements

Engineering Contradiction:
Improvemeasurement reliabilityVSAvoidradioactive hazard
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention replaces radioactive labeling with fluorescence-based RET labeling. Instead of using radiolabeled ligands that pose safety hazards, the assay uses fluorophore-labeled GTP analogues and antibodies that provide equivalent measurement reliability without ionizing radiation, thereby eliminating the harmful radioactive effects while maintaining detection sensitivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Measurement precision

If washing steps and membrane filtration are required, then measurement precision is improved, but ease of operation decreases making HTS difficult

Engineering Contradiction:
Improvesignal accuracyVSAvoidassay simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The invention employs RET-based detection where the signal is generated directly by the interaction between labeled GTP analogues and labeled alpha subunits within the membrane preparation. The energy transfer signal is inherently specific to the bound complex, allowing detection without washing steps or filtration to remove unbound reagents. This self-distinguishing capability maintains signal accuracy while dramatically simplifying the assay procedure for high-throughput screening.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides a sensitive and reliable method for modulating GPCR activation, allowing discrimination of alpha G-protein subtypes in a single membrane preparation, suitable for high-throughput screening without radioactive materials.

Implementation Method 1

A method using fluorescence-based Resonance Energy Transfer (RET) to detect nonhydrolyzable or slowly hydrolyzable GTP labeled with RET partners

Methodology Applied
Scientific EffectResonance Energy Transfer:

Implementation Method 2

fluorescence-based Resonance Energy Transfer (RET) to detect nonhydrolyzable or slowly hydrolyzable GTP labeled with RET partners

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12584916B2Method for measuring the modulation of the activation of a G protein-coupled receptor with GTP analogues
Publication Date: 2026.03.24 CISBIO BIOASSAYS
  • US12584916B2 patent drawing
  • US12584916B2 patent drawing
  • US12584916B2 patent drawing

AI summary

The invention relates to a method for determining the ability of a molecule to modulate the activation of a G protein-coupled receptor (GPCR), said method comprising the following steps:a) introducing, in a first container:a membrane preparation bearing one or more GPCRs and one or more alpha G-proteins,a source of nonhydrolyzable or slowly hydrolyzable GTP labeled with a first member of a pair of RET partners,a ligand of the alpha subunit of a G protein (alpha G-protein) labeled with a second member of the pair of RET partners, said ligand being capable of binding to the full alpha G-protein bound to the nonhydrolyzable or slowly hydrolyzable GTP labeled with the first member of a pair of RET partners,optionally a GPCR agonist;b) measuring the RET signal emitted in the first container;c) introducing (i) in a second container, the same reagents as in step a) and the molecule to be assayed or (ii) in the first container, the molecule to be assayed;d) measuring the RET signal emitted in the second container or in the first container obtained in step c);e) comparing the signals obtained in steps b) and d), a modulation of the signal obtained in step d) relative to that obtained in step b) indicating that the molecule to be tested is capable of modulating the activation of the GPCR.